Services

Tools and expertise to navigate translational research challenges with confidence.

Our flexible engagement structure enables biotech organizations to access the scientific depth they need — from focused analytical support to integrated translational strategy and executive-level advisory.

We work at your critical points

Clinical candidate selection

01

Preclinical Proof-of-concept

02

IND-enabling studies

Pharmacology and toxicology

03

Monitoring and real-time comprehensive reporting of Phase 1 readouts

04

Clinical Proof-of-mechanism and early efficacy signals

05

Biomarker discovery and validation

06

Go/No-Go and RP2D

07

Partnering and investor data rooms

08

Core Capabilities

High-Dimensional Data Generation & Interpretation

>
Flow cytometry scRNAseq RNA-seq Multiplexed solubles Proteomics

We design, oversee and analyze studies with high-parameter readouts or mine public data and extract the relevant insights from them.

Preclinical Study Design, Oversight & Reporting

>
Safety Efficacy FIH-enabling data packages

We write protocols with the clinical question in mind, oversee execution and translate outputs into regulatory-facing reports.

Translational Biomarker Strategy & Assay Development

>
Discovery → fit-for-purpose clinical assay

We build biomarker strategies grounded in your mechanism and mode of action, then help you develop and validate the assays needed to test them in patients.

Clinical Trial Biomarker Analysis & Reporting

>
Mechanistic PD Immune monitoring Exploratory efficacy endpoints

We conduct exploratory analyses of non-primary endpoints to validate the MoA, gain mechanistic understanding, look for early signs of efficacy and associated biomarkers.

Scientific Oversight of External Partners

>
CROs Academic labs Specialty contractors

We provide scientific stewardship of your external network — ensuring protocol fidelity, data quality, and critical evaluation of deliverables.

Full coverage designed around evolving program needs.

A single, seamless partner spanning the entire translational pipeline - from preclinical evidence to clinical readouts - adapting in real-time as your program advances.

Let’s build the right scientific strategy for your program.

Start the Conversation